 Patients with obstructive sleep apnoea (OSA) should be treated concurrently for both chronic rhinosinusitis and OSA to optimize sleep dysfunction and quality of life improvement |
| Timothy L. Smith et al. | A new study, published online by JAMA Otolaryngology-Head & Neck Surgery, has found that the quality of life (QOL) for patients with chronic rhinosinusitis (CRS) and obstructive sleep apnoea (OSA) can be improved following endoscopic sinus surgery.
Timothy L. Smith, of Oregon Health & Science University, Portland, OR, USA, and colleagues investigated the impact of comorbid OSA on CRS disease-specific QOL and sleep dysfunction in patients with CRS following functional endoscopic sinus surgery (FESS). In their study, they included 405 patients with a diagnosis of CRS who underwent FESS, 60 of whom (15%) had comorbid OSA. A total of 285 patients (70%) provided preoperative and postoperative survey responses for various measures, with an average of 13.7 months of follow-up.
There was no difference between those with and without OSA in regard to disease severity or CRS disease-specific QOL, poor sleep or average sleep quality scores before surgery. Following FESS, substantial, and statistically significant, gains in QOL and disease severity were observed for patients with CRS with and without OSA. Those without OSA reported greater improvements on sleep quality.
The authors stated:
"Patients with OSA should be treated concurrently for both CRS and OSA to optimize sleep dysfunction and QOL improvement. Future investigations are needed to further elucidate the discordance and underlying mechanisms of sleep improvement between those patients with and without OSA with objective sleep measures".
|
